Assignee
BIOGEN SWISS MFG GMBH
CH·3 granted patents·5 pending applications·2 citations·filing 2018–2022
Top patents by PatentIndex Score
8 records- 0189US11229619B2Controlled release pharmaceutical compositions comprising a fumaric acid esterBIOGEN SWISS MFG GMBH·Filed 2018·Granted Jan 25, 2022·1 cites·19 claims
- 0284US11052062B2Controlled release pharmaceutical compositions comprising a fumaric acid esterBIOGEN SWISS MFG GMBH·Filed 2019·Granted Jul 6, 2021·1 cites·8 claims
- 0381US2022168255A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseBIOGEN SWISS MFG GMBH·Filed 2022·Application pending·0 cites
- 0481US2022105064A1Controlled release pharmaceutical compositions comprising a fumaric acid esterBIOGEN SWISS MFG GMBH·Filed 2021·Application pending·0 cites
- 0579US2021220318A1Controlled release pharmaceutical compositions comprising a fumaric acid esterBIOGEN SWISS MFG GMBH·Filed 2021·Application pending·0 cites
- 0675US2021290582A1Pharmaceutical composition containing dimethyl fumarate for administration at a low daily doseBIOGEN SWISS MFG GMBH·Filed 2020·Application pending·0 cites
- 0775US2022079884A1Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrixBIOGEN SWISS MFG GMBH·Filed 2021·Application pending·0 cites
- 0872US11173123B2Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrixBIOGEN SWISS MFG GMBH·Filed 2018·Granted Nov 16, 2021·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when BIOGEN SWISS MFG GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →